Two compounds, one research theme

BPC-157 is a synthetic peptide based on a short sequence identified in a protein found in gastric juice. In the literature it is often referred to as a body-protection compound, and it is studied for its signalling role in the nitric-oxide and angiogenic pathways, the biology of how tissue is supplied with blood.

TB-500 is a synthetic fragment corresponding to the active region of thymosin beta-4, a naturally occurring protein. Research interest centres on its relationship to actin, the structural protein involved in cell movement and migration. The two peptides sit inside the same broad research theme, tissue repair, while acting through different mechanisms of study.

How they differ

The two are easy to blur together because they appear in the same forums and the same shopping baskets. Set side by side, though, the distinctions are clear, and they matter to how each one is studied.

• Origin sequenceBPC-157 derives from a gastric protein fragment; TB-500 is modelled on the active region of thymosin beta-4. Different parent molecules, different starting points.
• Mechanism of studyBPC-157 is examined mainly around nitric-oxide and angiogenic signalling; TB-500 is examined around actin regulation and cell migration.
• Research framingBoth appear in localised and systemic tissue-repair models, but the questions asked of each are distinct rather than interchangeable.
• FormatBoth are supplied as lyophilised powder for reconstitution, so handling and storage are effectively the same.

Availability in Australia

At Polaris Research we stock BPC-157 as a 10mg standalone vial, and we also carry a BPC-157 and TB-500 blend in a single 10mg vial for researchers who want both sequences in one preparation. We do not sell TB-500 as a standalone product.

That makes the blend the practical route to studying TB-500 alongside BPC-157 through us. If your work calls for a single-sequence BPC-157 preparation, the standalone vial is the one to choose; if the protocol involves both sequences, the blend saves reconstituting two separate vials.

Which researchers pick which

Researchers focused narrowly on the BPC-157 sequence tend to choose the standalone vial, because it keeps a single variable in the frame and makes any observation easier to read. Introducing a second compound at the same time makes it harder to attribute a result to one sequence or the other.

Researchers looking at the combined tissue-repair theme, where both the angiogenic and actin-related pathways are of interest, tend to reach for the blend. As a general rule, isolate first and combine later, so you have a baseline for each sequence before studying them together.

Certificates, handling, and delivery

Whichever preparation you choose, the practicalities match. Every vial ships with an independently verified Certificate of Analysis (COA) confirming identity and purity, which you can check against the batch number on the label. Reconstitute with Bacteriostatic Water added slowly down the wall of the vial, never directly onto the powder, and swirl rather than shake.

Orders include Free Express Delivery Australia-wide and dispatch within 2 business days of confirmed payment. Store lyophilised vials cool and dark, and keep any reconstituted solution refrigerated.